Related Experiment Video
Updated: May 12, 2026
05:24
Teratoma Generation in the Testis Capsule
Published on: November 7, 2011
Growing teratoma syndrome: Brief communication and algorithm for management
Kevin Byrd1, Michael P Stany, Natasha C Herbold
1Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, MD 20889, USA.
Summary
Growing teratoma syndrome (GTS) is a rare ovarian tumor complication. Recognizing GTS prevents unnecessary chemotherapy and guides optimal management for affected women.
Area of Science:
- Gynecologic Oncology
- Reproductive Endocrinology
Background:
- Growing teratoma syndrome (GTS) is a rare sequela in women diagnosed with ovarian germ cell tumors.
- It typically manifests after systemic chemotherapy, characterized by normalized tumor markers and a residual mature teratoma.
Observation:
- This report details five clinical cases of ovarian GTS, highlighting the diagnostic and therapeutic challenges.
- Patients presented with persistent or recurrent masses despite initial treatment for germ cell tumors.
Findings:
- The key finding is the pathological confirmation of mature teratoma in the presence of normalized tumor markers post-chemotherapy.
- This presentation necessitates a re-evaluation of the treatment strategy, moving away from further cytotoxic therapy.
Implications:
- Increased awareness of GTS is crucial for clinicians managing ovarian germ cell tumors.
- Implementing a structured diagnostic algorithm can prevent overtreatment and ensure appropriate surgical or surveillance management.
- This approach optimizes patient outcomes and reduces the morbidity associated with unnecessary chemotherapy.
